BioGalen Pharmaceuticals

Metronidazole Suspension

Anti-Parasitic · Oral Suspension · 200mg/5ml

WhatsApp Enquiry

Trade Information

Minimum Order Qty 100,000 bottles
Capacity 5 Million Bottles per month
Strength 200mg/5ml
Private Labelling Custom branding, artwork & market-specific labelling
Lead Time 45–60 days from order confirmation
Payment Terms LC at sight, TT (advance / against documents)
Shipping FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia BP, USP, IP compliant

Packing Options

  • Suspension bottle (glass / PET)
  • Bottle with measuring cup
  • Hospital bulk pack
  • Custom packing as per buyer requirement

Regulatory & Quality

Registration Status Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification WHO-GMP Certified

Product Details

Composition Metronidazole
Dosage Form Oral Suspension
Pack Size Bottle with measuring cup (60ml / 100ml) / Custom packing available
Storage Store below 30°C in a dry place, protected from light
Shelf Life 24 months from date of manufacture

Description

Metronidazole is a nitroimidazole agent with a distinctive dual role against both protozoal infections and anaerobic bacteria. It is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Metronidazole as an oral suspension (200 mg/5 ml). Its dual antiprotozoal and anti-anaerobic role gives it broad demand across community and programme channels.

Mechanism of Action

Metronidazole is a nitroimidazole that is selectively taken up by anaerobic bacteria and protozoa. Inside these organisms its nitro group is reduced to reactive intermediates that damage DNA and inhibit nucleic acid synthesis, killing the cell. Because this reduction occurs only in low-oxygen environments, Metronidazole is selectively active against anaerobes and protozoa while sparing aerobic human cells, giving it its characteristic dual antiprotozoal and anti-anaerobic activity.

Indications

  • Amoebiasis and giardiasis
  • Anaerobic bacterial infections
  • Dental and oral infections
  • Bacterial vaginosis and trichomoniasis
  • Intestinal and dental anaerobic infections

Available Variants

  • Metronidazole Oral Suspension 200mg/5ml

Frequently Asked Questions

What is Metronidazole used for?
Metronidazole is a nitroimidazole with a dual role: it treats protozoal infections such as amoebiasis and giardiasis, and anaerobic bacterial infections including dental and intestinal infections.
What forms of Metronidazole does BioGalen manufacture?
BioGalen manufactures Metronidazole as an oral suspension (200 mg/5 ml), under WHO-GMP with CTD and ACTD dossiers available, serving retail and programme channels.
Is Metronidazole suspension suitable for paediatric use?
Yes. BioGalen manufactures Metronidazole as an oral suspension (200 mg/5 ml) suitable for paediatric dosing of protozoal and anaerobic infections, supplied to importers, distributors, and programmes.

Interested in Metronidazole Suspension?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.